Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-357329
Filing Date
2017-11-30
Accepted
2017-11-30 16:17:52
Documents
4
Effectiveness Date
2017-11-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d626621ds8.htm S-8 41246
2 EX-5.1 d626621dex51.htm EX-5.1 6400
3 EX-23.1 d626621dex231.htm EX-23.1 1491
4 GRAPHIC g626621g73x39.jpg GRAPHIC 2482
  Complete submission text file 0001193125-17-357329.txt   53858
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-221827 | Film No.: 171231467
SIC: 2836 Biological Products, (No Diagnostic Substances)